Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Nov;71(11):8531–8541. doi: 10.1128/jvi.71.11.8531-8541.1997

An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.

S L Buge 1, E Richardson 1, S Alipanah 1, P Markham 1, S Cheng 1, N Kalyan 1, C J Miller 1, M Lubeck 1, S Udem 1, J Eldridge 1, M Robert-Guroff 1
PMCID: PMC192317  PMID: 9343211

Abstract

Six female rhesus macaques were immunized orally and intranasally at 0 weeks and intratracheally at 12 weeks with an adenovirus type 5 host range mutant (Ad5hr)-simian immunodeficiency virus SIVsm env recombinant and at 24 and 36 weeks with native SIVmac251 gp120 in Syntex adjuvant. Four macaques received the Ad5hr vector and adjuvant alone; two additional controls were naive. In vivo replication of the Ad5hr wild-type and recombinant vectors occurred with detection of Ad5 DNA in stool samples and/or nasal secretions in all macaques and increases in Ad5 neutralizing antibody in 9 of 10 macaques following Ad administrations. SIV-specific neutralizing antibodies appeared after the second recombinant immunization and rose to titers > 10,000 following the second subunit boost. Immunoglobulin G (IgG) and IgA antibodies able to bind gp120 developed in nasal and rectal secretions, and SIV-specific IgGs were also observed in vaginal secretions and saliva. T-cell proliferative responses to SIV gp140 and T-helper epitopes were sporadically detected in all immunized macaques. Following vaginal challenge with SIVmac251, transient or persistent infection resulted in both immunized and control monkeys. The mean viral burden in persistently infected immunized macaques was significantly decreased in the primary infection period compared to that of control macaques. These results establish in vivo use of the Ad5hr vector, which overcomes the host range restriction of human Ads for rhesus macaques, thereby providing a new model for evaluation of Ad-based vaccines. In addition, they show that a vaccine regimen using the Ad5hr-SIV env recombinant and gp120 subunit induces strong humoral, cellular, and mucosal immunity in rhesus macaques. The reduced viral burden achieved solely with an env-based vaccine supports further development of Ad-based vaccines comprising additional viral components for immune therapy and AIDS vaccine development.

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander N. J. Sexual transmission of human immunodeficiency virus: virus entry into the male and female genital tract. World Health Organization, Global Programme on Acquired Immune Deficiency Syndrome. Fertil Steril. 1990 Jul;54(1):1–18. doi: 10.1016/s0015-0282(16)53628-0. [DOI] [PubMed] [Google Scholar]
  2. Berman P. W., Gregory T. J., Riddle L., Nakamura G. R., Champe M. A., Porter J. P., Wurm F. M., Hershberg R. D., Cobb E. K., Eichberg J. W. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature. 1990 Jun 14;345(6276):622–625. doi: 10.1038/345622a0. [DOI] [PubMed] [Google Scholar]
  3. Boom R., Sol C. J., Salimans M. M., Jansen C. L., Wertheim-van Dillen P. M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J Clin Microbiol. 1990 Mar;28(3):495–503. doi: 10.1128/jcm.28.3.495-503.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. COUCH R. B., CHANOCK R. M., CATE T. R., LANG D. J., KNIGHT V., HUEBNER R. J. IMMUNIZATION WITH TYPES 4 AND 7 ADENOVIRUS BY SELECTIVE INFECTION OF THE INTESTINAL TRACT. Am Rev Respir Dis. 1963 Sep;88:SUPPL–403. doi: 10.1164/arrd.1963.88.3P2.394. [DOI] [PubMed] [Google Scholar]
  5. Chakrabarti S., Brechling K., Moss B. Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol Cell Biol. 1985 Dec;5(12):3403–3409. doi: 10.1128/mcb.5.12.3403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cheng S. M., Lee S. G., Ronchetti-Blume M., Virk K. P., Mizutani S., Eichberg J. W., Davis A., Hung P. P., Hirsch V. M., Chanock R. M. Coexpression of the simian immunodeficiency virus Env and Rev proteins by a recombinant human adenovirus host range mutant. J Virol. 1992 Nov;66(11):6721–6727. doi: 10.1128/jvi.66.11.6721-6727.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chengalvala M., Lubeck M. D., Davis A. R., Mizutani S., Molnar-Kimber K., Morin J., Hung P. P. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine. 1991 Jul;9(7):485–490. doi: 10.1016/0264-410x(91)90033-3. [DOI] [PubMed] [Google Scholar]
  8. Clumeck N., Sonnet J., Taelman H., Mascart-Lemone F., De Bruyere M., Vandeperre P., Dasnoy J., Marcelis L., Lamy M., Jonas C. Acquired immunodeficiency syndrome in African patients. N Engl J Med. 1984 Feb 23;310(8):492–497. doi: 10.1056/NEJM198402233100804. [DOI] [PubMed] [Google Scholar]
  9. Conley M. E., Delacroix D. L. Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense? Ann Intern Med. 1987 Jun;106(6):892–899. doi: 10.7326/0003-4819-106-6-892. [DOI] [PubMed] [Google Scholar]
  10. Davis A. R., Kostek B., Mason B. B., Hsiao C. L., Morin J., Dheer S. K., Hung P. P. Expression of hepatitis B surface antigen with a recombinant adenovirus. Proc Natl Acad Sci U S A. 1985 Nov;82(22):7560–7564. doi: 10.1073/pnas.82.22.7560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. De Schryver A., Meheus A. Epidemiology of sexually transmitted diseases: the global picture. Bull World Health Organ. 1990;68(5):639–654. [PMC free article] [PubMed] [Google Scholar]
  12. Dewar R. L., Natarajan V., Vasudevachari M. B., Salzman N. P. Synthesis and processing of human immunodeficiency virus type 1 envelope proteins encoded by a recombinant human adenovirus. J Virol. 1989 Jan;63(1):129–136. doi: 10.1128/jvi.63.1.129-136.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Franchini G., Markham P., Gard E., Fargnoli K., Keubaruwa S., Jagodzinski L., Robert-Guroff M., Lusso P., Ford G., Wong-Staal F. Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects. J Virol. 1990 Sep;64(9):4462–4467. doi: 10.1128/jvi.64.9.4462-4467.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirsch V. M., Fuerst T. R., Sutter G., Carroll M. W., Yang L. C., Goldstein S., Piatak M., Jr, Elkins W. R., Alvord W. G., Montefiori D. C. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. J Virol. 1996 Jun;70(6):3741–3752. doi: 10.1128/jvi.70.6.3741-3752.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hospedales J. Heterosexual spread of HIV infection. Rev Infect Dis. 1989 Jul-Aug;11(4):663–665. doi: 10.1093/clinids/11.4.663a. [DOI] [PubMed] [Google Scholar]
  16. Hu S. L., Abrams K., Barber G. N., Moran P., Zarling J. M., Langlois A. J., Kuller L., Morton W. R., Benveniste R. E. Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160. Science. 1992 Jan 24;255(5043):456–459. doi: 10.1126/science.1531159. [DOI] [PubMed] [Google Scholar]
  17. Johnson A. M. Heterosexual transmission of human immunodeficiency virus. Br Med J (Clin Res Ed) 1988 Apr 9;296(6628):1017–1020. doi: 10.1136/bmj.296.6628.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kalyanaraman V. S., Rodriguez V., Veronese F., Rahman R., Lusso P., DeVico A. L., Copeland T., Oroszlan S., Gallo R. C., Sarngadharan M. G. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1990 Mar;6(3):371–380. doi: 10.1089/aid.1990.6.371. [DOI] [PubMed] [Google Scholar]
  19. Kanki P. J., Alroy J., Essex M. Isolation of T-lymphotropic retrovirus related to HTLV-III/LAV from wild-caught African green monkeys. Science. 1985 Nov 22;230(4728):951–954. doi: 10.1126/science.2997923. [DOI] [PubMed] [Google Scholar]
  20. Koenig S., Hirsch V. M., Olmsted R. A., Powell D., Maury W., Rabson A., Fauci A. S., Purcell R. H., Johnson P. R. Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2443–2447. doi: 10.1073/pnas.86.7.2443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Koplan J. P., Hardy A. M., Allen J. R. Epidemiology of the acquired immunodeficiency syndrome in intravenous drug abusers. Adv Alcohol Subst Abuse. 1985 Fall;5(1-2):13–23. doi: 10.1300/J251v05n01_02. [DOI] [PubMed] [Google Scholar]
  22. Kozlowski P. A., Black K. P., Shen L., Jackson S. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG. J Immunol. 1995 Jun 1;154(11):6163–6173. [PubMed] [Google Scholar]
  23. Kreiss J. K., Koech D., Plummer F. A., Holmes K. K., Lightfoote M., Piot P., Ronald A. R., Ndinya-Achola J. O., D'Costa L. J., Roberts P. AIDS virus infection in Nairobi prostitutes. Spread of the epidemic to East Africa. N Engl J Med. 1986 Feb 13;314(7):414–418. doi: 10.1056/NEJM198602133140704. [DOI] [PubMed] [Google Scholar]
  24. Lange J. M., van den Berg H., Dooren L. J., Vossen J. M., Kuis W., Goudsmit J. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins. J Infect Dis. 1986 Jul;154(1):171–174. doi: 10.1093/infdis/154.1.171. [DOI] [PubMed] [Google Scholar]
  25. Lehner T., Bergmeier L. A., Tao L., Panagiotidi C., Klavinskis L. S., Hussain L., Ward R. G., Meyers N., Adams S. E., Gearing A. J. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen to elicit genital, rectal, and urinary immune responses in nonhuman primates. J Immunol. 1994 Aug 15;153(4):1858–1868. [PubMed] [Google Scholar]
  26. Lehner T., Tao L., Panagiotidi C., Klavinskis L. S., Brookes R., Hussain L., Meyers N., Adams S. E., Gearing A. J., Bergmeier L. A. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J Virol. 1994 Mar;68(3):1624–1632. doi: 10.1128/jvi.68.3.1624-1632.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lehner T., Wang Y., Cranage M., Bergmeier L. A., Mitchell E., Tao L., Hall G., Dennis M., Cook N., Brookes R. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med. 1996 Jul;2(7):767–775. doi: 10.1038/nm0796-767. [DOI] [PubMed] [Google Scholar]
  28. Lohman B. L., McChesney M. B., Miller C. J., McGowan E., Joye S. M., Van Rompay K. K., Reay E., Antipa L., Pedersen N. C., Marthas M. L. A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge. J Virol. 1994 Nov;68(11):7021–7029. doi: 10.1128/jvi.68.11.7021-7029.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lohman B. L., McChesney M. B., Miller C. J., Otsyula M., Berardi C. J., Marthas M. L. Mucosal immunization with a live, virulence-attenuated simian immunodeficiency virus (SIV) vaccine elicits antiviral cytotoxic T lymphocytes and antibodies in rhesus macaques. J Med Primatol. 1994 Feb-May;23(2-3):95–101. doi: 10.1111/j.1600-0684.1994.tb00108.x. [DOI] [PubMed] [Google Scholar]
  30. Lubeck M. D., Natuk R. J., Chengalvala M., Chanda P. K., Murthy K. K., Murthy S., Mizutani S., Lee S. G., Wade M. S., Bhat B. M. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1443–1449. doi: 10.1089/aid.1994.10.1443. [DOI] [PubMed] [Google Scholar]
  31. Lubeck M. D., Natuk R., Myagkikh M., Kalyan N., Aldrich K., Sinangil F., Alipanah S., Murthy S. C., Chanda P. K., Nigida S. M., Jr Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization. Nat Med. 1997 Jun;3(6):651–658. doi: 10.1038/nm0697-651. [DOI] [PubMed] [Google Scholar]
  32. Marthas M. L., Miller C. J., Sutjipto S., Higgins J., Torten J., Lohman B. L., Unger R. E., Ramos R. A., Kiyono H., McGhee J. R. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against vaginal challenge with virulent SIV. J Med Primatol. 1992 Feb-May;21(2-3):99–107. [PubMed] [Google Scholar]
  33. Marx P. A., Compans R. W., Gettie A., Staas J. K., Gilley R. M., Mulligan M. J., Yamshchikov G. V., Chen D., Eldridge J. H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 1993 May 28;260(5112):1323–1327. doi: 10.1126/science.8493576. [DOI] [PubMed] [Google Scholar]
  34. Mestecky J., Kutteh W. H., Jackson S. Mucosal immunity in the female genital tract: relevance to vaccination efforts against the human immunodeficiency virus. AIDS Res Hum Retroviruses. 1994;10 (Suppl 2):S11–S20. [PubMed] [Google Scholar]
  35. Mestecky J., McGhee J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153–245. doi: 10.1016/s0065-2776(08)60240-0. [DOI] [PubMed] [Google Scholar]
  36. Miller C. J., Marthas M., Torten J., Alexander N. J., Moore J. P., Doncel G. F., Hendrickx A. G. Intravaginal inoculation of rhesus macaques with cell-free simian immunodeficiency virus results in persistent or transient viremia. J Virol. 1994 Oct;68(10):6391–6400. doi: 10.1128/jvi.68.10.6391-6400.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Miller C. J., McChesney M. B., Lü X., Dailey P. J., Chutkowski C., Lu D., Brosio P., Roberts B., Lu Y. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol. 1997 Mar;71(3):1911–1921. doi: 10.1128/jvi.71.3.1911-1921.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Natuk R. J., Chanda P. K., Lubeck M. D., Davis A. R., Wilhelm J., Hjorth R., Wade M. S., Bhat B. M., Mizutani S., Lee S. Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7777–7781. doi: 10.1073/pnas.89.16.7777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Natuk R. J., Davis A. R., Chanda P. K., Lubeck M. D., Chengalvala M., Murthy S. C., Wade M. S., Dheer S. K., Bhat B. M., Murthy K. K. Adenovirus vectored vaccines. Dev Biol Stand. 1994;82:71–77. [PubMed] [Google Scholar]
  40. Natuk R. J., Lubeck M. D., Chanda P. K., Chengalvala M., Wade M. S., Murthy S. C., Wilhelm J., Vernon S. K., Dheer S. K., Mizutani S. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees. AIDS Res Hum Retroviruses. 1993 May;9(5):395–404. doi: 10.1089/aid.1993.9.395. [DOI] [PubMed] [Google Scholar]
  41. Pela A. O., Platt J. J. AIDS in Africa: emerging trends. Soc Sci Med. 1989;28(1):1–8. doi: 10.1016/0277-9536(89)90298-0. [DOI] [PubMed] [Google Scholar]
  42. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  43. Prevec L., Christie B. S., Laurie K. E., Bailey M. M., Graham F. L., Rosenthal K. L. Immune response to HIV-1 gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. J Acquir Immune Defic Syndr. 1991;4(6):568–576. [PubMed] [Google Scholar]
  44. Prince A. M., Reesink H., Pascual D., Horowitz B., Hewlett I., Murthy K. K., Cobb K. E., Eichberg J. W. Prevention of HIV infection by passive immunization with HIV immunoglobulin. AIDS Res Hum Retroviruses. 1991 Dec;7(12):971–973. doi: 10.1089/aid.1991.7.971. [DOI] [PubMed] [Google Scholar]
  45. Quinn T. C. AIDS in Africa: evidence for heterosexual transmission of the human immunodeficiency virus. N Y State J Med. 1987 May;87(5):286–289. [PubMed] [Google Scholar]
  46. Quinn T. C., Mann J. M., Curran J. W., Piot P. AIDS in Africa: an epidemiologic paradigm. Science. 1986 Nov 21;234(4779):955–963. doi: 10.1126/science.3022379. [DOI] [PubMed] [Google Scholar]
  47. Romano J. W., Williams K. G., Shurtliff R. N., Ginocchio C., Kaplan M. NASBA technology: isothermal RNA amplification in qualitative and quantitative diagnostics. Immunol Invest. 1997 Jan-Feb;26(1-2):15–28. doi: 10.3109/08820139709048912. [DOI] [PubMed] [Google Scholar]
  48. Schneider M., Graham F. L., Prevec L. Expression of the glycoprotein of vesicular stomatitis virus by infectious adenovirus vectors. J Gen Virol. 1989 Feb;70(Pt 2):417–427. doi: 10.1099/0022-1317-70-2-417. [DOI] [PubMed] [Google Scholar]
  49. Top F. H., Jr, Buescher E. L., Bancroft W. H., Russell P. K. Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7. J Infect Dis. 1971 Aug;124(2):155–160. doi: 10.1093/infdis/124.2.155. [DOI] [PubMed] [Google Scholar]
  50. Voss G., Li J., Manson K., Wyand M., Sodroski J., Letvin N. L. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology. 1995 Apr 20;208(2):770–775. doi: 10.1006/viro.1995.1209. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES